NEUROONE MEDICAL TECHNOLOGIES Corp
NMTC· Nasdaq
NMTCNEUROONE MEDICAL TECHNOLOGIES Corp
Filed Dec 22, 2022 · 10-K · 83 days after period end · 0001213900-22-081897
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021 | Q4 2020 | Q4 2019dderived from reported figures |
|---|---|---|---|---|
| Revenue | $68.79K | $33.75K | $71.47K | — |
| Net Income | -$1.37M | -$2.81M | -$1.96M | -$1.35M |
| EPS Diluted | — | -$0.18 | -$0.26 | — |
NEUROONE MEDICAL TECHNOLOGIES Corp · CIK 1500198 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Sep 30, 2022 · filed Dec 22, 2022 · 83 d after period end
